San Ramon, CA • Fremont, CA
- Gout Studies (2)
- Actinic Keratosis
- Asthma
- Influenza
- Rheumatoid Arthritis (Fremont Location)
- Lupus (Fremont Location)
Future studies: GERD, High Cholesterol, Coronary Heart Disease, Type 2 Diabetes, Various Skin Conditions, Back Pain, Erectile Dysfunction, Hypertension, COPD
Actinic Keratosis (Sun Damaged Skin)
If you have been diagnosed with Actinic Keratosis, you may be eligible to participate in a clinical research study of an investigational gel. This research study is being conducted to compare the safety and effectiveness of a study gel for Actinic Keratosis to that of a marketed gel or a placebo.
Study participants will receive the investigational study gel, and all study related testing and examinations at no cost. Compensation for time and travel may be available.
If you are interested in more information or to see if you qualify, please contact Tim at 925-413-1451 or tdavis@westcoastresearch.com.Gout Study #1
Are you or a loved one still having gout attacks despite taking your gout medication? If so, you may qualify for a local clinical research study of an investigational gout medication that is designed to work differently than most other drugs. Doctors are studying this medication to see if it may lower uric acid levels and possibly relieve gout symptoms.
All study related supplies, procedures and study visits will be provided at no charge to you or your insurance company. Financial compensation for time and travel may also be provided.
If you are interested in more information or to see if you qualify, please contact Tim at 925-413-1451 or tdavis@westcoastresearch.com.
Gout Study #2
This is a 5-year study to evaluate the safety of Febuxostat and Allopurinol. Study-related medical care and services are provided at no cost to study participants. Compensation for time and travel will be provided.
You may qualify to participate if you:
- Female, 55 years or older
- Male, 50 years or older
- Have gout and a history of cardiac disease like stroke or heart attack or blood circulation problems
All study related supplies, procedures and study visits will be provided at no charge to you or your insurance company. Financial compensation for time and travel may also be provided.
If you are interested in more information or to see if you qualify, please contact Tim at 925-413-1451 or tdavis@westcoastresearch.com.
Asthma Study
Do you have asthma? You may qualify for an asthma research study if you:
-
Are 18 years of age or older
-
Have had asthma for at least for one year
-
Are receiving asthma treatment
-
Have had asthma bad enough to see a doctor in the last 12 months
-
There is no placebo (inactive substance, sometimes referred to as a sugar pill) in this clinical research study.
-
There will be no blood draws (no needles) during this clinical research study.
-
Qualified study participants will receive asthma medication and study related care for asthma.
-
Reimbursement for time and travel may be provided.
If you are interested in more information or to see if you qualify, please contact Tim at 925-413-1451 or tdavis@westcoastresearch.com.
Influenza Study
If you are experiencing a fever, cough, fatigue, stuffy nose, sore throat or headache? You may have the Flu.
We are conducting a clinical trial to study the safety and effectiveness of an investigational medication with and without Oseltamivar (Tamiflu) in treating uncomplicated influenza better known as “THE FLU”
If you are between the ages of 18 and 65 years old have a fever of at least 100.4 and are experiencing flu symptoms you may qualify. You MUST be seen within 48 hours of the onset of symptoms.
All study procedures will done at no cost and you may be compensated for time and travel.
If you are interested in more information or to see if you qualify, please contact Tim at 925-413-1451 or tdavis@westcoastresearch.com.
Rheumatoid Arthritis (Fremont Location)
A randomized, double-blind, placebo-controlled study of secukinumab to demonstrate the efficacy at 24 weeks and to assess the safety, tolerability and long term efficacy up to 2 years in patients with active rheumatoid arthritis who have an inadequate response to anti-TNFα agents(AIN457).
The purpose of this study is to demonstrate at Week 24 the efficacy and assess the safety of secukinumab given as intravenous (i.v.) loading doses, followed by sub-cutaneous (s.c.) injections of 2 dose levels of secukinumab versus placebo in patients with active RA who are intolerant to or have had an inadequate response to anti-TNF-α agents, and to provide efficacy/safety data for filing of secukinumab in RA with health authorities globally. Patients will have to be on background MTX therapy throughout the study. At Week 24, efficacy will be assessed based on signs and symptoms according to the American College of Rheumatology response criteria (ACR20 response). Treatment will continue up to 2 years to assess the long term efficacy (especially on structural damage) and safety of secukinumab treatment with combination with MTX in RA.
You may qualify for the research research study if you:
- Presence of RA classified by ACR 2010 revised criteria for at least 3 months before screening
- patients need to have been intolerant or shown inadequate response to at least 1 DMARD
- Patients must be taking MTX for at least 3 months before randomization and have to be on a stable dose at least 4 weeks before randomization
If you are interested in more information or to see if you qualify, please contact Tim at 925-413-1451 or tdavis@westcoastresearch.com.
Lupus (Fremont Location)
A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab.
If you are interested in more information or to see if you qualify, please contact Tim at 925-413-1451 or tdavis@westcoastresearch.com.
Contact Information
To find out more information about a specific study, please call 925-413-1451 or email tdavis@westcoastresearch.com. Our staff will be able to tell you more about the research study and answer your questions.
 |
Click here to be added to our database and notified of future studies |